VCG
TNDM icon

Vantage Consulting Group’s Tandem Diabetes Care TNDM Stock Holding History

Vantage Consulting Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14
Closed -$1K – 1440
2020
Q4 		$1K Buy
+14
New +$1.44K ﹤0.01% 1806

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vantage Consulting Group's TNDM Position: Q1 2021 in Review

Vantage Consulting Group sold out of Tandem Diabetes Care (TNDM) in Q1 2021, closing a stake of 14 shares — an estimated $1K sold.

Vantage Consulting Group first reported a position in TNDM in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

  • Vantage Consulting Group reported no remaining Tandem Diabetes Care position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 14 Tandem Diabetes Care shares in Q1 2021, an estimated $1K.
  • Vantage Consulting Group first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Tandem Diabetes Care position peaked at $1K in Q4 2020.
  • 290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.